Search results (100)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
Oxford receives funding to develop a cancer prevention vaccine for Lynch syndrome
10 September 2024
Cancer Research UK funds University of Oxford scientists to develop ‘LynchVax’, the UK’s first vaccine aiming to prevent cancer in people with Lynch syndrome who have a much higher risk of developing several types of cancer.
Oxford hosts industry event on cancer precision prevention trials
17 July 2024
Professor Sarah Blagden led a panel discussion focused on the opportunities of cancer precision prevention.
OxCODE researchers at the inaugural Cancer Prevention Research conference 2024
4 July 2024
Over 20 Oxford researchers engaged with over 350 attendees from all over the world at a truly interdisciplinary cancer prevention conference.
GambitBio: empowering early detection at home
2 July 2024
GambitBio is developing an at-home lateral flow test to screen for the most common cancers, empowering people to take control of their health and reduce the number of cancer-related deaths. CRUK recently interviewed CEO, Tiffany Ma, who co-founded the venture while completing her DPhil at the University of Oxford.
Oxford Cancer: 5 minutes with Professor Dame Molly Stevens
23 May 2024
Professor Dame Molly Stevens is John Black Professor of Bionanoscience in the Department of Physiology, Anatomy and Genetics and the Institute of Biomedical Engineering. She recently moved her lab from Imperial College London to the University of Oxford and the Kavli Institute for nanoscience discovery, and she is joining the Oxford Cancer community.
Blood proteins may be able to predict risk of cancer more than seven years before it is diagnosed
15 May 2024
Proteins linked to cancer can start appearing in people’s blood more than seven years before they’re diagnosed. In the future, it’s possible doctors could use these early warning signs to find and treat cancer much earlier than they’re able to today.
OCION Funding Scheme: In conversation with David Church and Luciana Gneo
10 May 2024
The mission of the Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is to pump-prime innovative Oxford-based immuno-oncology research and build capacity in cancer immunology. We sat down with 2023 awardees, David Church and Luciana Gneo, to discuss what research the fund will enable them to carry out.
Researchers develop new way to identify people with new-onset diabetes who are at risk of pancreatic cancer
8 May 2024
The new method could help people with new-onset diabetes at high-risk of developing pancreatic cancer to be identified more accurately so that they can be monitored.
University of Oxford Lung cancer trial reaches 400 participants
8 April 2024
The SCOOT study seeks current and former smokers across England to provide blood samples for ongoing research aiming to improve lung cancer diagnosis.
£1.7 million for vaccine to prevent lung cancer
22 March 2024
Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.
Funding to compare imaging modalities for liver cancer detection
15 March 2024
The DeLIVER team will evaluate non-contrast-enhanced MRI and compare it to standard of care ultrasound in a cohort of patients under surveillance for liver cancer.
Ultrasensitive detection of p53 cancer biomarker
15 March 2024
Professor Jason Davis and team have developed a new sensor to selectively and quantitatively measure p53 autoantibodies in the blood, levels of which are raised in a broad range of cancers.
Crowd-sourcing approach assesses current methods for improved automated detection and boundary mapping of colorectal cancer precursors
5 February 2024
A computer vision challenge was set to objectively quantify the generalisability of polyp detection and mapping algorithms, and challenge participants to innovate novel methods.
World Cancer Day: Oxford University professors on the record with their contribution to the fight against cancer
4 February 2024
Principal Investigators at the University talk candidly about their work and how they’re helping the fight against cancer.
First patient recruited to MILI trial
26 January 2024
Oxford’s first precision prevention cancer trial in people with Li Fraumeni Syndrome has opened to recruitment
Prof Anna Schuh launches first private specialised haematology clinic and laboratory in sub-Saharan Africa.
23 October 2023
SerenOx Africa aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility will also aim to provide early cancer detection for high-risk patients.
Collaboration announced to develop the use of AI to evaluate Barrett’s oesophagus
6 October 2023
An agreement between Satisfai Health Inc and the University of Oxford will progress the automated assessment of Barrett’s oesophagus with the aim of determining patients most at risk of developing oesophageal cancer.
OxCODE travel awards 2023
25 September 2023
Congratulations to James Chettle, Masato Inoue and Eoghan Mulholland who have been awarded OxCODE funds to attend this year’s Early Detection of Cancer conference in London.
Disentangling a long-standing link between inflammation and cancer progression
11 September 2023
A study led by the Mead Group has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant blood stem cells, shedding light on the progression of leukaemia.
New Study Offers Hope in Early Detection of Breast Cancer
24 August 2023
A team of researchers led by the Nuffield Department of Primary Care Health Sciences, have developed a new model that reliably predicts a woman's likelihood of developing and then dying of breast cancer within a decade.